Julia Rohlhill
Associate Director, Viral Vector Sciences, Legend Biotech
Julia Rohlhill is listed as Associate Director, Viral Vector Sciences, Legend Biotech. Julia is scheduled to speak at Advanced Therapies Week 2027 on 19 January 2027.
Compiled from published conference agendas; not yet confirmed by Julia. Is this you? Claim this profile.
About
Julia Rohlhill is the Associate Director of Viral Vector Sciences at Legend Biotech. As a CMC and external lead, she spearheads technical development, external supply, and development strategy. Julia works directly with CDMOs to manufacture viral vectors for pipeline programs. Her expertise lies in in vivo lentiviral vector (LVV) therapies, focusing on scalability and robust production for direct-to-patient applications.
Upcoming
Advanced Therapies Week 2027 19 January 2027 – 21 January 2027
Announced as a speaker.